01 1Alcon Laboratories, Inc.
02 1Maithri Drugs Private Limited
03 1Regis Technologies Inc.
01 1NETARSUDIL MESYLATE
02 1Netarsudil Dimesylate
03 1Netarsudil Mesylate
01 1India
02 2U.S.A
NDC Package Code : 70727-324
Start Marketing Date : 2017-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-026
Start Marketing Date : 2021-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12817-815
Start Marketing Date : 2024-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Netarsudil Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Netarsudil Mesylate, including repackagers and relabelers. The FDA regulates Netarsudil Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Netarsudil Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Netarsudil Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Netarsudil Mesylate supplier is an individual or a company that provides Netarsudil Mesylate active pharmaceutical ingredient (API) or Netarsudil Mesylate finished formulations upon request. The Netarsudil Mesylate suppliers may include Netarsudil Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Netarsudil Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Netarsudil Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Netarsudil Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Netarsudil Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Netarsudil Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Netarsudil Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Netarsudil Mesylate suppliers with NDC on PharmaCompass.
We have 3 companies offering Netarsudil Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
